OptimizeRx Corp Quarterly Operating Margin in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
OptimizeRx Corp quarterly/annual Operating Margin history and growth rate from Q4 2011 to Q3 2024.
  • OptimizeRx Corp Operating Margin for the quarter ending September 30, 2024 was -32.1 %, a 23.3% decline year-over-year.
  • OptimizeRx Corp annual Operating Margin for 2023 was -36.9 %, a 87.5% decline from 2022.
  • OptimizeRx Corp annual Operating Margin for 2022 was -19.7 %, a 3441% decline from 2021.
  • OptimizeRx Corp annual Operating Margin for 2021 was 0.59 %.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -32.1 -6.07 -23.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -28 -1.11 -4.13% Apr 1, 2024 Jun 30, 2024
Q1 2024 -31.2 -5.89 -23.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -36.9 -17.2 -87.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -26 -8.88 -51.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -26.9 -15.9 -146% Apr 1, 2023 Jun 30, 2023
Q1 2023 -25.3 -20.9 -483% Jan 1, 2023 Mar 31, 2023
Q4 2022 -19.7 -20.3 -3441% Oct 1, 2022 Dec 31, 2022
Q3 2022 -17.1 -19 -996% Jul 1, 2022 Sep 30, 2022
Q2 2022 -10.9 -12.6 -742% Apr 1, 2022 Jun 30, 2022
Q1 2022 -4.33 -3.23 -295% Jan 1, 2022 Mar 31, 2022
Q4 2021 0.59 +5.52 Oct 1, 2021 Dec 31, 2021
Q3 2021 1.91 +18.9 Jul 1, 2021 Sep 30, 2021
Q2 2021 1.7 +28.2 Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.1 +21.5 +95.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -4.93 +10.1 +67.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -17 -10.7 -169% Jul 1, 2020 Sep 30, 2020
Q2 2020 -26.5 -29.4 -1004% Apr 1, 2020 Jun 30, 2020
Q1 2020 -22.6 -24.8 -1099% Jan 1, 2020 Mar 31, 2020
Q4 2019 -15 -15.9 -1867% Oct 1, 2019 Dec 31, 2019
Q3 2019 -6.31 -6.66 -1873% Jul 1, 2019 Sep 30, 2019
Q2 2019 2.93 +7.75 Apr 1, 2019 Jun 30, 2019
Q1 2019 2.26 +12.4 Jan 1, 2019 Mar 31, 2019
Q4 2018 0.85 +18.4 Oct 1, 2018 Dec 31, 2018
Q3 2018 0.36 +22.1 Jul 1, 2018 Sep 30, 2018
Q2 2018 -4.82 +15.8 +76.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -10.2 +15.8 +60.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -17.6 +2.84 +13.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 -21.7 +0.1 +0.46% Jul 1, 2017 Sep 30, 2017
Q2 2017 -20.7 -3.86 -23% Apr 1, 2017 Jun 30, 2017
Q1 2017 -25.9 -14.6 -129% Jan 1, 2017 Mar 31, 2017
Q4 2016 -20.4 -12.1 -147% Oct 1, 2016 Dec 31, 2016
Q3 2016 -21.8 -22.5 -3279% Jul 1, 2016 Sep 30, 2016
Q2 2016 -16.8 -12 -252% Apr 1, 2016 Jun 30, 2016
Q1 2016 -11.3 -5.71 -102% Jan 1, 2016 Mar 31, 2016
Q4 2015 -8.27 +7.51 +47.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 0.69 +32.5 Jul 1, 2015 Sep 30, 2015
Q2 2015 -4.78 +27.7 +85.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -5.61 +17.6 +75.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -15.8 -10.1 -176% Oct 1, 2014 Dec 31, 2014
Q3 2014 -31.8 -40 -485% Jul 1, 2014 Sep 30, 2014
Q2 2014 -32.5 -43.7 -389% Apr 1, 2014 Jun 30, 2014
Q1 2014 -23.2 -21.3 -1085% Jan 1, 2014 Mar 31, 2014
Q4 2013 -5.72 +17.2 +75% Oct 1, 2013 Dec 31, 2013
Q3 2013 8.26 +61.7 Jul 1, 2013 Sep 30, 2013
Q2 2013 11.2 +97.1 Apr 1, 2013 Jun 30, 2013
Q1 2013 -1.96 +143 +98.6% Jan 1, 2013 Mar 31, 2013
Q4 2012 -22.9 +108 +82.5% Oct 1, 2012 Dec 31, 2012
Q3 2012 -53.4 Jul 1, 2012 Sep 30, 2012
Q2 2012 -85.9 Apr 1, 2012 Jun 30, 2012
Q1 2012 -145 Jan 1, 2012 Mar 31, 2012
Q4 2011 -131 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.